From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...
Bristol-Myers Squibb faces patent risks but has promising new drugs. Find out why BMY stock remains a "Buy" with strong ...
We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look ...
Jefferies upgraded Bristol-Myers Squibb Company (NYSE:BMY) to "buy" from "hold" and raised its price target by $7 to $70, amid an improved confidence in the company’s product pipeline, disciplined ...
Bristol-Myers Squibb Inc. (NYSE: BMY) shares saw are trading higher Monday. Jefferies analyst, Akash Tewari, raised his ...
We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...
Bristol-Myers Squibb Co. plotted to rip off investors in a 2016 acquisition through legal gamesmanship aimed at evading a ...
Lilly's and Bristol Myers Squibb's plans, prompting lawsuits. Sanofi simply proceeded without an OK. The hospital industry warns if the drug companies prevail, that would hamper HRSA's authority ...